Expand RNA Menu
RNA MENU

RNA Latest Press Releases

-- April 23, 2026 --

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration PRNewswire 8:00 AM

-- April 20, 2026 --

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PRNewswire 10:47 PM

-- February 27, 2026 --

Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies PRNewswire 9:20 AM

-- February 26, 2026 --

Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference PRNewswire 4:03 PM

-- February 23, 2026 --

Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders PRNewswire 8:00 AM

-- February 18, 2026 --

The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1 PRNewswire 5:00 PM

-- February 2, 2026 --

Avidity Biosciences Announces Expected Record Date for Spin-Off PRNewswire 9:45 PM

-- January 31, 2026 --

Halper Sadeh LLC Encourages TWO, RNA, CVBF, TBN Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 12:58 PM

-- January 30, 2026 --

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TBHC, RNA, NEW, and TWO PRNewswire 10:46 PM

-- January 28, 2026 --

Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development ACCESS Newswire 4:15 PM

-- December 1, 2025 --

Halper Sadeh LLC Encourages RNA, TCBX, ATXS, FSUN Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 6:59 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--TCBX, RNA, ATXS, and FSUN PRNewswire 3:20 PM
Market Data Delayed 15 Minutes